Jason Chamberlain

639 total citations
13 papers, 368 citations indexed

About

Jason Chamberlain is a scholar working on Surgery, Nephrology and Genetics. According to data from OpenAlex, Jason Chamberlain has authored 13 papers receiving a total of 368 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Surgery, 5 papers in Nephrology and 5 papers in Genetics. Recurrent topics in Jason Chamberlain's work include Mesenchymal stem cell research (5 papers), Gout, Hyperuricemia, Uric Acid (5 papers) and Ophthalmology and Eye Disorders (2 papers). Jason Chamberlain is often cited by papers focused on Mesenchymal stem cell research (5 papers), Gout, Hyperuricemia, Uric Acid (5 papers) and Ophthalmology and Eye Disorders (2 papers). Jason Chamberlain collaborates with scholars based in United States. Jason Chamberlain's co-authors include Esmail D. Zanjani, Graça Almeida‐Porada, Christopher D. Porada, Evan Colletti, Ali Torabi, A. M. Frias, John S. Pixley, Judith A. Airey, Neil D. Theise and Takashi Yamagami and has published in prestigious journals such as Circulation, Blood and Hepatology.

In The Last Decade

Jason Chamberlain

12 papers receiving 359 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jason Chamberlain United States 7 202 189 116 113 44 13 368
Èlia Ripoll Spain 11 122 0.6× 120 0.6× 160 1.4× 7 0.1× 32 0.7× 17 424
Yorick Soeder Germany 7 186 0.9× 242 1.3× 83 0.7× 18 0.2× 4 0.1× 10 401
Isabelle Leisten Germany 6 44 0.2× 109 0.6× 129 1.1× 6 0.1× 72 1.6× 9 342
Lakshmi Kugathasan Canada 7 146 0.7× 110 0.6× 177 1.5× 24 0.2× 6 0.1× 14 525
Jean-Paul Duong-Van-Huyen France 5 189 0.9× 59 0.3× 153 1.3× 11 0.1× 93 2.1× 8 475
Sarah Appleby New Zealand 9 41 0.2× 29 0.2× 101 0.9× 26 0.2× 13 0.3× 21 356
Masao Nakasatomi Japan 9 31 0.2× 33 0.2× 105 0.9× 15 0.1× 49 1.1× 21 263
Giuseppe Loffredo Italy 12 68 0.3× 72 0.4× 88 0.8× 8 0.1× 37 0.8× 17 490
Nicola Corcione Italy 11 125 0.6× 34 0.2× 75 0.6× 6 0.1× 9 0.2× 59 451

Countries citing papers authored by Jason Chamberlain

Since Specialization
Citations

This map shows the geographic impact of Jason Chamberlain's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jason Chamberlain with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jason Chamberlain more than expected).

Fields of papers citing papers by Jason Chamberlain

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jason Chamberlain. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jason Chamberlain. The network helps show where Jason Chamberlain may publish in the future.

Co-authorship network of co-authors of Jason Chamberlain

This figure shows the co-authorship network connecting the top 25 collaborators of Jason Chamberlain. A scholar is included among the top collaborators of Jason Chamberlain based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jason Chamberlain. Jason Chamberlain is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Abdellatif, Abdul, et al.. (2023). Pegloticase efficacy and safety in kidney transplant recipients; results of the phase IV, open‐label PROTECT clinical trial. Clinical Transplantation. 37(9). e14993–e14993. 5 indexed citations
2.
Saag, Kenneth G., Stephen Ong, K. Obermeyer, et al.. (2022). A Randomized, Placebo‐Controlled Study of Methotrexate to Increase Response Rates in Patients with Uncontrolled Gout Receiving Pegloticase: Primary Efficacy and Safety Findings. Arthritis & Rheumatology. 75(2). 293–304. 35 indexed citations
3.
4.
5.
Yan, Xin, Fengyan Xu, Yuying Gao, et al.. (2021). Pharmacokinetics and Exposure-Response Relationship of Teprotumumab, an Insulin-Like Growth Factor-1 Receptor-Blocking Antibody, in Thyroid Eye Disease. Clinical Pharmacokinetics. 60(8). 1029–1040. 18 indexed citations
6.
Weinblatt, Michael E., et al.. (2021). POS1136 PHARMACOKINETICS OF PEGLOTICASE AND METHOTREXATE POLYGLUTAMATE(S) IN PATIENTS WITH UNCONTROLLED GOUT RECEIVING PEGLOTICASE AND CO-TREATMENT OF METHOTREXATE. Annals of the Rheumatic Diseases. 80. 847–848. 1 indexed citations
7.
8.
Chamberlain, Jason, Takashi Yamagami, Evan Colletti, et al.. (2007). Efficient generation of human hepatocytes by the intrahepatic delivery of clonal human mesenchymal stem cells in fetal sheep. Hepatology. 46(6). 1935–1945. 112 indexed citations
9.
Colletti, Evan, Graça Almeida‐Porada, Jason Chamberlain, Esmail D. Zanjani, & Judith A. Airey. (2006). The time course of engraftment of human mesenchymal stem cells in fetal heart demonstrates that Purkinje fiber aggregates derive from a single cell and not multi-cell homing. Experimental Hematology. 34(7). 926–933. 9 indexed citations
10.
Chamberlain, Jason, et al.. (2005). Proteomic Analysis Reveals Intrinsic Differences between Phenotypically Identical Mesenchymal Stem Cells.. Blood. 106(11). 395–395. 5 indexed citations
11.
Almeida‐Porada, Graça, Christopher D. Porada, Jason Chamberlain, Ali Torabi, & Esmail D. Zanjani. (2004). Formation of human hepatocytes by human hematopoietic stem cells in sheep. Blood. 104(8). 2582–2590. 99 indexed citations
12.
Airey, Judith A., Graça Almeida‐Porada, Evan Colletti, et al.. (2004). Human Mesenchymal Stem Cells Form Purkinje Fibers in Fetal Sheep Heart. Circulation. 109(11). 1401–1407. 72 indexed citations
13.
Chamberlain, Jason. (1968). Rheumatoid disease in association with basal cell carcinoma.. PubMed. 96(11). 1110–2. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Èlia Ripoll Breakdown of academic impact, for papers by Yorick Soeder Breakdown of academic impact, for papers by Isabelle Leisten Breakdown of academic impact, for papers by Lakshmi Kugathasan Breakdown of academic impact, for papers by Jean-Paul Duong-Van-Huyen Breakdown of academic impact, for papers by Sarah Appleby Breakdown of academic impact, for papers by Masao Nakasatomi Breakdown of academic impact, for papers by Giuseppe Loffredo Breakdown of academic impact, for papers by Nicola Corcione
Rankless by CCL
2026